SEARCH

SEARCH BY CITATION

References

  • Bekar L., Libionka W., Tian G. F. et al. (2008) Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor. Nat. Med. 14, 7580.
  • Cassada D. C., Tribble C. G., Long S. M. et al. (2002) Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. J. Vasc. Surg. 35, 994998.
  • Chen J. F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M. A., Fink J. S. and Schwarzschild M. A. (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 91929200.
  • Chen J. F., Moratalla R., Impagnatiello F. et al. (2001) The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc. Natl Acad. Sci. USA 98, 19701975.
  • Chen J. F., Sonsalla P. K., Pedata F., Melani A., Domenici M. R., Popoli P., Geiger J., Lopes L. V. and de Mendonca A. (2007) Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and “fine tuning” modulation. Prog. Neurobiol. 83, 310331.
  • Chen X., Gawryluk J. W., Wagener J. F., Ghribi O. and Geiger J. D. (2008a) Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer’s disease. J Neuroinflammation 5, 12.
  • Chen X., Lan X., Roche I., Liu R. and Geiger J. D. (2008b) Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J. Neurochem. 107, 11471157.
  • Chen G. Q., Chen Y. Y., Wang X. S., Wu S. Z., Yang H. M., Xu H. Q., He J. C., Wang X. T., Chen J. F. and Zheng R. Y. (2010) Chronic caffeine treatment attenuates experimental autoimmune encephalomyelitis induced by guinea pig spinal cord homogenates in Wistar rats. Brain Res. 1309, 116125.
  • Cognato G. P., Agostinho P. M., Hockemeyer J., Muller C. E., Souza D. O. and Cunha R. A. (2010) Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life. J. Neurochem. 112, 453462.
  • Crawford M. P., Yan S. X., Ortega S. B. et al. (2004) High prevalence of autoreactive, neuroantigen-specific CD8+  T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103, 42224231.
  • Cunha R. A. (2005) Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal. 1, 111134.
  • Dai S. S., Zhou Y. G., Li W. et al. (2010) Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury. J. Neurosci. 30, 58025810.
  • Day Y. J., Huang L., McDuffie M. J., Rosin D. L., Ye H., Chen J. F., Schwarzschild M. A., Fink J. S., Linden J. and Okusa M. D. (2003) Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J. Clin. Invest. 112, 883891.
  • Day Y. J., Marshall M. A., Huang L., McDuffie M. J., Okusa M. D. and Linden J. (2004) Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G285G293.
  • DeAngelis T. and Lublin F. (2008) Multiple sclerosis: new treatment trials and emerging therapeutic targets. Curr. Opin. Neurol. 21, 261271.
  • Fletcher J. M., Lalor S. J., Sweeney C. M., Tubridy N. and Mills K. H. (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 162, 111.
  • Fontoura P., Steinman L. and Miller A. (2006) Emerging therapeutic targets in multiple sclerosis. Curr. Opin. Neurol. 19, 260266.
  • Goldman N., Chen M., Fujita T. et al. (2010) Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat. Neurosci. 13, 883888.
  • Hafler D. A. (2004) Multiple sclerosis. J. Clin. Invest. 113, 788794.
  • Hasko G., Kuhel D. G., Chen J. F., Schwarzschild M. A., Deitch E. A., Mabley J. G., Marton A. and Szabo C. (2000) Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14, 20652074.
  • Huseby E. S., Liggitt D., Brabb T., Schnabel B., Ohlen C. and Goverman J. (2001) A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med., 194, 669676.
  • Ji Q. and Goverman J. (2007) Experimental autoimmune encephalomyelitis mediated by CD8 +  T cells. Ann. N. Y. Acad. Sci. 1103, 157166.
  • Johnston J. B., Silva C., Gonzalez G., Holden J., Warren K. G., Metz L. M. and Power C. (2001) Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis. Ann. Neurol. 49, 650658.
  • Keegan B. M. and Noseworthy J. H. (2002) Multiple sclerosis. Annu. Rev. Med. 53, 285302.
  • Kim J. H., Budde M. D., Liang H. F., Klein R. S., Russell J. H., Cross A. H. and Song S. K. (2006) Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol. Dis. 21, 626632.
  • Li X. L., Lv J., Xi N. N., Wang T., Shang X. F., Xu H. Q., Han Z., O’Byrne K. T., Li X. F. and Zheng R. Y. (2010) Neonatal endotoxin exposure suppresses experimental autoimmune central nervous system of adult rats. Biochem. Biophys. Res. Commun. 398, 302308.
  • Liedtke W., Edelmann W., Chiu F. C., Kucherlapati R. and Raine C. S. (1998) Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am. J. Pathol. 152, 251259.
  • Linker R. A., Lee D. H., Demir S. et al. (2010) Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 133, 22482263.
  • Mayne M., Shepel P. N., Jiang Y., Geiger J. D. and Power C. (1999) Dysregulation of adenosine A1 receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients. Ann. Neurol. 45, 633639.
  • Mayne M., Fotheringham J., Yan H. J., Power C., Del Bigio M. R., Peeling J. and Geiger J. D. (2001) Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann. Neurol. 49, 727735.
  • McFarland H. F. and Martin R. (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913919.
  • Melani A., Pantoni L., Bordoni F., Gianfriddo M., Bianchi L., Vannucchi M. G., Bertorelli R., Monopoli A. and Pedata F. (2003) The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res. 959, 243250.
  • Mills J. H., Thompson L. F., Mueller C., Waickman A. T., Jalkanen S., Niemela J., Airas L. and Bynoe M. S. (2008) CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 105, 93259330.
  • Murray T. J. (2006) Diagnosis and treatment of multiple sclerosis. BMJ, 332, 525527.
  • Noseworthy J. H., Lucchinetti C., Rodriguez M. and Weinshenker B. G. (2000) Multiple sclerosis. N. Engl. J. Med. 343, 938952.
  • Ohta A. and Sitkovsky M. (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916920.
  • Okuda Y., Sakoda S., Fujimura H., Saeki Y., Kishimoto T. and Yanagihara T. (1999) IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J. Neuroimmunol. 101, 188196.
  • Pozzilli C., Marinelli F., Romano S. and Bagnato F. (2004) Corticosteroids treatment. J. Neurol. Sci. 223, 4751.
  • Prineas J. W. and Wright R. G. (1978) Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38, 409421.
  • Richardson P. J., Gubitz A. K., Freeman T. C. and Dixon A. K. (1999) Adenosine receptor antagonists and Parkinson’s disease: actions of the A2A receptor in the striatum. Adv. Neurol. 80, 111119.
  • Schwarzschild M. A., Agnati L., Fuxe K., Chen J. F. and Morelli M. (2006) Targeting adenosine A2A receptors in Parkinson’s disease. Trends Neurosci. 29, 647654.
  • Sitkovsky M. V., Lukashev D., Apasov S., Kojima H., Koshiba M., Caldwell C., Ohta A. and Thiel M. (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22, 657682.
  • Steinman L. and Zamvil S. S. (2006) How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60, 1221.
  • Sun D., Whitaker J. N., Huang Z., Liu D., Coleclough C., Wekerle H. and Raine C. S. (2001) Myelin antigen-specific CD8 +  T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166, 75797587.
  • Tebano M. T., Martire A., Potenza R. L., Gro C., Pepponi R., Armida M., Domenici M. R., Schwarzschild M. A., Chen J. F. and Popoli P. (2008) Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus. J. Neurochem. 104, 279286.
  • Thiel M., Chouker A., Ohta A., Jackson E., Caldwell C., Smith P., Lukashev D., Bittmann I. and Sitkovsky M. V. (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3, e174.
  • Tischner D. and Reichardt H. M. (2007) Glucocorticoids in the control of neuroinflammation. Mol. Cell. Endocrinol. 275, 6270.
  • Tsutsui S., Schnermann J., Noorbakhsh F., Henry S., Yong V. W., Winston B. W., Warren K. and Power C. (2004) A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J. Neurosci. 24, 15211529.
  • Tsutsui S., Vergote D., Shariat N., Warren K., Ferguson S. S. and Power C. (2008) Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells. FASEB J. 22, 786796.
  • Von Lubitz D. K., Lin R. C. and Jacobson K. A. (1995) Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist. Eur. J. Pharmacol. 287, 295302.
  • Wang X. S., Chen Y. Y., Shang X. F. et al. (2009) Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis. Brain Res. 1253, 198209.
  • Wang P., Wang Z. W., Lin F. H., Han Z., Hou S. T. and Zheng R. Y. (2011) 2-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity. Biochem. Biophys. Res. Commun. 406, 152157.
  • Weaver A., Goncalves da Silva A., Nuttall R. K., Edwards D. R., Shapiro S. D., Rivest S. and Yong V. W. (2005) An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1/Th2 polarization. FASEB J. 19, 16681670.
  • Wei C. J., Singer P., Coelho J., Boison D., Feldon J., Yee B. K. and Chen J. F. (2011) Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. Learn. Mem. 18, 459474.
  • Yang Z., Day Y. J., Toufektsian M. C., Xu Y., Ramos S. I., Marshall M. A., French B. A. and Linden J. (2006) Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4 +  T lymphocytes. Circulation 114, 20562064.
  • Yu L., Haverty P. M., Mariani J., Wang Y., Shen H. Y., Schwarzschild M. A., Weng Z. and Chen J. F. (2005) Genetic and pharmacological inactivation of adenosine A2A receptor reveals an Egr-2-mediated transcriptional regulatory network in the mouse striatum. Physiol. Genomics 23, 89102.
  • Yu L., Shen H. Y., Coelho J. E. et al. (2008) Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann. Neurol. 63, 338346.